Eri Oda

3.6k citations

34 papers · 2.9k indexed · 1 hit paper · h-index 13

Impact in

Oncology top 2%
- Cancer-related Molecular Pathways
- Cytokine Signaling Pathways and Interactions
Immunology top 5%
- interferon and immune responses

Papers in ⓘ

Hepatology 6
- Hepatocellular Carcinoma Treatment and Prognosis 6
Oncology 13
- Cytokine Signaling Pathways and Interactions 4
- Cancer-related Molecular Pathways 3

Co-authors: Nobuyuki Tanaka (7 shared papers)Tadatsugu Taniguchi (7 shared papers)Hideki Murasawa (3 shared papers)Tsukasa Shibue (2 shared papers)Rieko Ohki (2 shared papers)Toshiharu Yamashita (1 shared paper)Takashi Tokino (1 shared paper)Mitsuharu Sato (2 shared papers)
Journals: Anticancer Research (9 papers)Molecular and Cellular Biology (3 papers)Molecular Genetics and Metabolism (2 papers)Brain and Development (2 papers)British Journal of Cancer (1 paper)
Partner nations: Japan United States Netherlands

In The Last Decade

Eri Oda

29 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis 2000 · 1.7k citations

Peers

Countries citing papers authored by Eri Oda

Since Specialization

Citations

This map shows the geographic impact of Eri Oda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eri Oda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eri Oda more than expected).

Fields of papers citing papers by Eri Oda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eri Oda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eri Oda. The network helps show where Eri Oda may publish in the future.

Co-authors

The 25 scholars most cited alongside Eri Oda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eri Oda Line = papers co-authored together Eri Oda links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis Science ·Eri Oda, Rieko Ohki, Hideki Murasawa, Jiro Nemoto, Tsukasa Shibue, Toshiharu Yamashita, Takashi Tokino, Tadatsugu Taniguchi, Nobuyuki Tanaka Hit paper breakdown →	2000	1685
2	Integral role of Noxa in p53-mediated apoptotic response Genes & Development ·Tsukasa Shibue, Kiyoshi Takeda, Eri Oda, Hiroshi Tanaka, Hideki Murasawa, Akinori Takaoka, Yasuyuki Morishita, Shizuo Akira, Tadatsugu Taniguchi, Nobuyuki Tanaka	2003	269
3	Involvement of the IRF family transcription factor IRF‐3 in virus‐induced activation of the IFN‐β gene FEBS Letters ·Mitsuharu Sato, Nobuyuki Tanaka, Naoki Hata, Eri Oda, Tadatsugu Taniguchi	1998	222
4	Reprimo, a New Candidate Mediator of the p53-mediated Cell Cycle Arrest at the G2 Phase Journal of Biological Chemistry ·Rieko Ohki, Jiro Nemoto, Hideki Murasawa, Eri Oda, Johji Inazawa, Nobuyuki Tanaka, Tadatsugu Taniguchi	2000	162
5	Type I interferons are essential mediators of apoptotic death in virally infected cells Genes to Cells ·Nobuyuki Tanaka, Mitsuharu Sato, Marc S. Lamphier, Hiroaki Nozawa, Eri Oda, Shigeru Noguchi, Robert D. Schreiber, Yoshihide Tsujimoto, Tadatsugu Taniguchi	1998	144
6	Functionally inactivating point mutation in the tumor-suppressorIRF-1 gene identified in human gastric cancer International Journal of Cancer ·Hiroaki Nozawa, Eri Oda, Seiji Ueda, Gen Tamura, Chihaya Maesawa, Tetsuichiro Muto, Tadatsugu Taniguchi, Nobuyuki Tanaka	1998	76
7	High frequency of acid α-glucosidase pseudodeficiency complicates newborn screening for glycogen storage disease type II in the Japanese population Molecular Genetics and Metabolism ·Shingo Kumamoto, Tatsuya Katafuchi, Kimitoshi Nakamura, Fumio Endo, Eri Oda, Torayuki Okuyama, Marian A. Kroos, Arnold Reuser, Toshika Okumiya	2009	48
8	Critical role for constitutive type I interferon signaling in the prevention of cellular transformation Cancer Science ·Huimin Chen, Nobuyuki Tanaka, Yukiko Mitani, Eri Oda, Hiroaki Nozawa, Jian‐zhong Chen, Hideyuki Yanai, Hideo Negishi, Myoung Kwon Choi, Toshiroh Iwasaki, Hiroyuki Yamamoto, Tadatsugu Taniguchi, Akinori Takaoka	2008	46
9	Risk factors for pulmonary morbidities after minimally invasive esophagectomy for esophageal cancer Surgical Endoscopy ·Tomoyuki Uchihara, Naoya Yoshida, Yoshifumi Baba, Taisuke Yagi, Tasuku Toihata, Eri Oda, Daisuke Kuroda, Tsugio Eto, Mayuko Ohuchi, Kenichi Nakamura, Hiroshi Sawayama, Koichi Kinoshita, Masaaki Iwatsuki, Takatsugu Ishimoto, Yasuo Sakamoto, Hideo Baba	2017	34
10	G10BP, an E1A-Inducible Negative Regulator of Sp1, Represses Transcription of the Rat Fibronectin Gene Molecular and Cellular Biology ·Mitsuhiro Suzuki, Chizuko Kuroda, Eri Oda, Shiho Tsunoda, Takeshi Nakamura, Takuma Nakajima, Kinichiro Oda	1995	32
11	Determination of the oxidative stress biomarker urinary 8-hydroxy-2⿲-deoxyguanosine by automated on-line in-tube solid-phase microextraction coupled with liquid chromatographytandem mass spectrometry Journal of Chromatography B ·Hiroyuki Kataoka, Keisuke Mizuno, Eri Oda, Akihiro Saito	2015	30
12	Newborn screening for Pompe disease in Japan Molecular Genetics and Metabolism ·Eri Oda, Toju Tanaka, Ohsuke Migita, Motomichi Kosuga, Masaru Fukushi, Toshika Okumiya, Makiko Ōsawa, Torayuki Okuyama	2011	27
13	Induction of Sp1 in Differentiating Human Embryonal Carcinoma Cells Triggers Transcription of the Fibronectin Gene Molecular and Cellular Biology ·Mitsuhiro Suzuki, Eri Oda, Takuma Nakajima, Souei Sekiya, Kinichiro Oda	1998	26
14	Cloning and Characterization of a GC-Box Binding Protein, G10BP-1, Responsible for Repression of the Rat Fibronectin Gene Molecular and Cellular Biology ·Eri Oda, Kenna Shirasuna, Mitsuhiro Suzuki, Kuniko Nakano, Takuma Nakajima, Kinichiro Oda	1998	9
15	Close monitoring of initial enzyme replacement therapy in a patient with childhood-onset Pompe disease Brain and Development ·Keiko Ishigaki, Terumi Murakami, Toshio Nakanishi, Eri Oda, Takatoshi Sato, Makiko Ōsawa	2011	9
16	Presence of Fusobacterium nucleatum in relation to patient survival and an acidic environment in oesophagogastric junction and gastric cancers British Journal of Cancer ·Yoshihiro Hara, Yoshifumi Baba, Eri Oda, Kazuto Harada, Kohei Yamashita, Tasuku Toihata, Keisuke Kosumi, Masaaki Iwatsuki, Yuji Miyamoto, Hiroyasu Tsutsuki, Qiong Gan, Rebecca Waters, Yoshihiro Komohara, Tomohiro Sawa, Jaffer A. Ajani, Hideo Baba	2024	7
17	Reconstruction Using a Pedunculated Gastric Tube with Duodenal Transection After Esophagectomy and Pharyngolaryngectomy Annals of Surgical Oncology ·Naoya Yoshida, Yoshifumi Baba, Eri Oda, Keisuke Kosumi, Takatsugu Ishimoto, Masayuki Watanabe, Yukiharu Hiyoshi, Shiro Iwagami, Junji Kurashige, Yasuo Sakamoto, Yuji Miyamoto, Hidetaka Sugihara, Kojiro Eto, Kazuto Harada, Hideo Baba	2015	6
18	Hepatic Inflammatory Pseudotumor Mimicking Malignant Tumor With Rare Onset of Intra-abdominal Hemorrhage Anticancer Research ·Kensuke Yamamura, Toru Beppu, Eri Oda, Nobutaka Sato, HIDEAKI YUKI, TOSHIHIKO MOTOHARA, Hideaki Miyamoto, Shunichi MIYAMURA, Kōji Onishi, YOSHIHIKO KOMOHARA, Shinichi Akahoshi	2021	5
19	A hepatic sclerosed hemangioma with drastic changes in contrast-enhanced ultrasonography Clinical Journal of Gastroenterology ·Shinichi Akahoshi, Kensuke Yamamura, Nobutaka Sato, Eri Oda, Koichi Kinoshita, Hideaki Yuki, TOSHIHIKO MOTOHARA, Akihiro Deguchi, Yoshihiro Komohara, Toru Beppu	2020	4
20	Complete Removal of Adrenal Metastasis in Hepatocellular Carcinoma Using Indocyanine Green Fluorescent Imaging Anticancer Research ·Kensuke Yamamura, Toru Beppu, Nobutaka Sato, Koichi Kinoshita, Eri Oda, HIDEAKI YUKI, TOSHIHIKO MOTOHARA, Hideaki Miyamoto, YOSHIHIKO KOMOHARA, Shinichi Akahoshi	2020	4

About Eri Oda

Eri Oda is a scholar working on Hepatology, Oncology, Rheumatology, Surgery and Immunology and Allergy, having authored 34 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cytokine Signaling Pathways and Interactions (4 papers), Lysosomal Storage Disorders Research (4 papers), interferon and immune responses (4 papers), Glycogen Storage Diseases and Myoclonus (4 papers), RNA Research and Splicing (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (616 citations), Molecular Biology (1.9k citations), Cancer Research (387 citations) and Biotechnology (172 citations). Eri Oda has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Nobuyuki Tanaka, Tadatsugu Taniguchi, Hideki Murasawa, Tsukasa Shibue, Rieko Ohki, Toshiharu Yamashita, Takashi Tokino, Mitsuharu Sato, Naoki Hata and Akinori Takaoka. Their work appears in journals such as Anticancer Research, Molecular and Cellular Biology, Molecular Genetics and Metabolism, Brain and Development and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact